Genomics and the Prospects of Existing and Emerging Therapeutics for Cardiovascular Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|15|27|3193-3206

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.27, 2009-09, pp. : 3193-3206

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aptamers as Therapeutics in Cardiovascular Diseases

By  

Current Medicinal Chemistry, Vol. 18, Iss. 27, 2011-09 ,pp. : 4169-4174

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging Peptide Therapeutics for Inflammatory Diseases

By  

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 4, 2006-08 ,pp. : 241-246

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging Peptide Therapeutics for Inflammatory Autoimmune Diseases

By  

Current Pharmaceutical Design, Vol. 16, Iss. 9, 2010-03 ,pp. : 1136-1142

Bentham Science Publishers

Access to resources Recommend Favorite

Nutraceuticals - An Emerging Era in the Treatment and Prevention of Cardiovascular Diseases

By  

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 1, 2006-02 ,pp. : 15-23

Bentham Science Publishers

Access to resources Recommend Favorite

Src inhibitors: genomics to therapeutics

By Sawyer Tomi   Boyce Brendan   Dalgarno David   Iuliucci John  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 7, 2001-07 ,pp. : 1327-1344

Informa Healthcare

Access to resources Recommend Favorite